Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
GlobeNewswire
· Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize..